(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 22.93 | 20.54 | 16.64 | 11.6% | 37.8% |
Total Expenses | 24.51 | 22.62 | 16.09 | 8.4% | 52.3% |
Profit Before Tax | -1.58 | -2.07 | 0.55 | -23.7% | -387.3% |
Tax | 0.25 | 8.25 | 0.54 | -97.0% | -53.7% |
Profit After Tax | -1.84 | -10.32 | 0.01 | -82.2% | -18500.0% |
Earnings Per Share | -0.20 | -1.20 | 0.00 | -83.3% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
JHS Svendgaard Laboratories Ltd is a company involved in the oral care industry, primarily engaged in the manufacturing of dental and oral hygiene products. The company produces a range of products including toothbrushes, toothpastes, and other oral care items under both its own brands and for third parties. Located in India, JHS Svendgaard operates in a competitive market, catering to both domestic and international clients. Any recent major developments about the company are not available within the provided data.
The total income for JHS Svendgaard Laboratories Ltd in Q3FY25 was ₹22.93 crores, reflecting an increase from ₹20.54 crores in Q2FY25 and ₹16.64 crores in Q3FY24. This represents a quarter-over-quarter (QoQ) growth of 11.6% and a year-over-year (YoY) increase of 37.8%. The observed growth in total income suggests an upward trend in revenue generation over both the quarter and the year.
In Q3FY25, JHS Svendgaard Laboratories Ltd reported a loss, with a profit before tax (PBT) of -₹1.58 crores, compared to -₹2.07 crores in Q2FY25 and a profit of ₹0.55 crores in Q3FY24. The QoQ change in PBT was a decrease of 23.7%, while the YoY change was -387.3%. The company incurred a tax of ₹0.25 crores in Q3FY25, significantly lower than the ₹8.25 crores in Q2FY25 and ₹0.54 crores in Q3FY24, representing a -97.0% QoQ change and -53.7% YoY change. The profit after tax (PAT) for Q3FY25 was -₹1.84 crores, improving from -₹10.32 crores in Q2FY25 but down from ₹0.01 crores in Q3FY24, with a QoQ change of -82.2% and a YoY change of -18500.0%.
The earnings per share (EPS) for JHS Svendgaard Laboratories Ltd in Q3FY25 was -₹0.20, an improvement from -₹1.20 in Q2FY25, with a QoQ change of -83.3%. No YoY percentage change is available for the EPS as the EPS was reported as ₹0.00 in Q3FY24. These operating metrics indicate fluctuations in the financial performance over the reported periods, with notable improvements in QoQ metrics despite negative values.
JHS Svendgaard Laboratories Ltd announced its Q1 FY 2025-26 results on 14 August, 2025.
JHS Svendgaard Laboratories Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of JHS Svendgaard Laboratories Ltd Q1 FY 2025-26 results include:
JHS Svendgaard Laboratories Ltd reported a net loss of ₹1.06 crore in Q1 FY 2025-26, reflecting a -268.3% year-over-year growth.
JHS Svendgaard Laboratories Ltd posted a revenue of ₹24.45 crore in Q1 FY 2025-26.